This conclusion is supported by a prior study that assessed PPI in a transgenic mouse model of tuberous sclerosis complex, another model of ASD and mTOR hyperactivation, which similarly reported no deficits in prepulse inhibition between WT and KO mice17. This evidence concerns the gene MTOR and tuberous sclerosis.